JOINT MEMORIAL · 1995–96 SESSION
HJM 4037: Drug review and approval
Memorializing the facilitation and approval of new drugs.
Summary
- Requests Congress to enact comprehensive legislation to facilitate the rapid review and approval of innovative new drugs, biological products, and medical devices, without compromising patient safety or product effectiveness.
From the Bill Digest (HJM 4037), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 23, 1996
- Out of committeestopped here
- Passed House
- Passed Senate
- Filed
- Prime sponsor
- Mike Sherstad (R-1)
- Introduced
- January 23, 1996 in the House
- Last action
- January 23, 1996
Sponsors
Prime sponsor: Mike Sherstad (R-1)
6 co-sponsors (2 Democrats, 4 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
The Legislature's online data doesn't include step-by-step history for sessions before 2001. Its final status is shown above, and the official bill page may have more.
HJM 4037 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HJM 4037 (2005–06) Medical practice
- HJM 4037 (2003–04) Employee free choice act
- HJM 4037 (1997–98) Tobacco litigation damages
- HJM 4037 (1991–92) Medicaid recip health care